When will Ifosfamide Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Ifosfamide Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Ifosfamide Injection

Brand names: Ifex, Ifosfamide

Category: Oncology, Pediatric

Unavailable 4Limited 1Available 3

FDA status: Current · Last FDA update: Sep 18, 2026 · First posted: Jun 12, 2026 (in shortage 3 months) · 4 manufacturers, 8 listed presentations

As of Sep 18, 2026, the FDA lists Ifosfamide Injection as currently in shortage. Of 8 manufacturer presentations, 4 Unavailable, 1 Limited, 3 Available.

Ask your pharmacist: which of the 4 manufacturers below can they order right now, and whether a different strength or form of Ifosfamide Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10) NDC 63323-142-10	Fresenius Kabi USA, LLC	Limited	Check wholesalers for inventory
Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02) NDC 21586-211-02	SteriMax, Inc.	Available	To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418
IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01) NDC 0338-3991-01	Baxter Healthcare	Unavailable	Estimated recovery: September 2026
Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01) NDC 10019-925-01	Baxter Healthcare	Available	-
IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01) NDC 0338-3993-01	Baxter Healthcare	Unavailable	Estimated recovery: October 2026
Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02) NDC 10019-926-02	Baxter Healthcare	Available	-
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01) NDC 0143-9531-01	Hikma Pharmaceuticals USA, Inc.	Unavailable	Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.
Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01) NDC 0143-9530-01	Hikma Pharmaceuticals USA, Inc.	Unavailable	Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released.

Related medications in shortage

Other Oncology, Pediatric medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Ifosfamide Injection (FDA data as of Sep 18, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Ifosfamide Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Ifosfamide Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/ifosfamide-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).